Grants Funded
Grant applicants for the 2024 cycle requested a total of nearly $3 million dollars. The PSF Study Section Subcommittees of Basic & Translational Research and Clinical Research evaluated more than 100 grant applications on the following topics:
The PSF awarded research grants totaling over $650,000 dollars to support more than 20 plastic surgery research proposals.
ASPS/PSF leadership is committed to continuing to provide high levels of investigator-initiated research support to ensure that plastic surgeons have the needed research resources to be pioneers and innovators in advancing the practice of medicine.
Research Abstracts
Search The PSF database to have easy access to full-text grant abstracts from past PSF-funded research projects 2003 to present. All abstracts are the work of the Principal Investigators and were retrieved from their PSF grant applications. Several different filters may be applied to locate abstracts specific to a particular focus area or PSF funding mechanism.
The Biomechanical Effects of Deferoxamine on Irradiated Soft Tissue
Ryan DeCoster M.D., Ph.D.
2019
University of Kentucky Research Foundation
Pilot Research Grant
Breast (Cosmetic / Reconstructive), General Reconstructive
Radiation therapy is an invaluable and necessary tool in the treatment of breast cancer, having been shown to improve both local disease control and overall survival. However, the ability of radiation to eradicate and control breast cancer causes damage to the skin surrounding the breast. This can lead to complications including infection, implant exposure, breast deformity, a poor cosmetic result, patient dissatisfaction, corrective surgery and reconstructive failure. In the United States, implant-based breast reconstruction is by far the most common type of breast reconstruction. Unfortunately, the nearly half of patients opting for implant-based breast reconstruction in the setting of radiation therapy experience complications which are thought to occur in part as a result of the changing of the mechanical properties of the skin. To date, no therapy has been developed to reduce the negative effects of radiation to the skin of the breast. The long-term goal of our laboratory is to find ways can lessen the negative effects of radiation on the skin in order to lower the high number of complications associated with an implant-based reconstructive approach. Deferoxamine is an FDA-approved medication that has been used off-label to improve some skin properties in radiated, experimental animal models of breast reconstruction. We believe that deferoxamine has the ability to improve the mechanical properties of irradiated skin, which would improve the overall quality of the skin. To investigate this, we will use an animal model of implant-based breast reconstruction that has been radiated and we will see how deferoxamine does on improving the mechanical properties of the skin when compared to a placebo. We have developed a tool to measure the mechanical properties of the skin using complex mathematics and we will also use another method called atomic force microscopy that will provide mechanical evidence at a level not visible to the human eye. Together, these two methods will give us a better idea of the effects deferoxamine may have on improving the mechanical properties of skin damaged by radiation. The results of this study will allow researchers and clinicians to draw more accurate conclusions about the mechanical effects of deferoxamine on skin that has been damaged by radiation which could have profound implications on lowering the high number of complications associated with radiation therapy and implant-based breast reconstruction in the future.
